Randomized phase II study of loratadine for the prevention of bone pain caused by pegfilgrastim
      QxMD      Google Scholar   
Citation:
Support Care Cancer vol 24 (7) 3085-3093
Year:
2016
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
5
Parents:
2136  
Children:
None
Program:
CCP
Primary Committee:
Symptom Inter
Sec. Committees:
Health Outcomes    
Pharmas:
 
Grants:
U10CA037447, U10 CA031946, U10 CA037447, U10 CA180821, UG1 CA189823  
Corr. Author:
 
Authors:
                         
Networks:
LAPS-MA036, LAPS-OH007, ME040, NEWMEXICO, VT004, WESTERN   
Study
NCT01311336
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
pegfilgrastim, bone pain, prophylaxis, antihistamine, loratadine, taxane